Kent, United Kingdom

Christopher Pickford

This inventor holds 1 USPTO granted patent. Top assignee: Centauri Therapeutics Limited (gb/gb). Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Pickford. Retrieved from https://idiyas.com/inventor/christopher-pickford-8q5yn6ox

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Pickford: Innovator in Therapeutics

Introduction

Christopher Pickford is a notable inventor based in Kent, GB. He has made significant contributions to the field of therapeutics, particularly in the development of novel compounds aimed at treating serious health conditions.

Latest Patents

Christopher holds a patent for "Compounds and therapeutics uses thereof." This invention relates to novel compounds that can link an immune response to a defined therapeutic target. It focuses on the use of these compounds in treating cancer and infectious diseases, as well as the compositions containing these compounds, the processes for their preparation, and the novel intermediates used in these processes. He has 1 patent to his name.

Career Highlights

Christopher is currently associated with Centauri Therapeutics Limited, where he applies his expertise in therapeutic innovations. His work is pivotal in advancing treatments that can significantly impact patient care and outcomes.

Collaborations

He collaborates with talented individuals such as Michael Westby and Melanie Glossop, contributing to a dynamic team focused on groundbreaking research and development.

Conclusion

Christopher Pickford's innovative work in therapeutics showcases his commitment to improving health outcomes through scientific advancements. His contributions are vital in the ongoing fight against cancer and infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…